Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032730

Options or other derivatives

  • Chief Scientific Officer acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hunt Hazel Chief Scientific Officer 2025-02-28 Grant or award · Stock Option (right to buy) +140,000 140,000 D
Loading xslF345X05/ownership.xml…